
Mesa Laboratories Inc. has executed its financial strategy by repaying $97.5 million of its Convertible Senior Notes that were due on Aug. 15, 2025. To fund this repayment, the company drew $97 million under its existing Credit Agreement, bringing its total outstanding balance to $108 million. The proceeds from this drawdown were utilized to settle…